Chair
Email: eelyobas@ust.hk
Tel: +852-2358-7068
My research is mainly focused on silicon-based micro/nanofabrication and lab-on-a-chip micro/nanofluidic technologies for life sciences, drug discovery and point-of-care diagnostics. These technologies often use electrokinetic principles such as electrophoresis, dielectrophoresis, and electrohydrodynamics along with micro/nanostructures such as integrated nanocapillaries and non-planar microelectrodes. Current thrust areas of my research include biomedical microdevices for (a) cell manipulation, sorting, and treatment for the isolation and analysis of rare cells such as circulating tumor cells and (b) rapid biomacromolecule separation for on-chip analysis of proteins and nucleic acids.
Co-Chair
Email: jabbari@engr.sc.edu
Tel: 803-777-8022
Prof. Jabbari’s research thrusts include the fundamental and practical aspects in the development of novel medical implants for growth factor and stem cell delivery in regenerative medicine and cancer therapy. His research exploits biomimetic principles and micro/nano-scale technologies to develop multi-cellular tissue models to understand the effect of microenvironment on tissue organization and maintenance.
Advisory Board
colin.j.brenan@ieee.org
e.angelini@imperial.ac.uk
Members
The mission of the Bettinger Group at CMU is to design, synthesize, and process synthetic polymers into medical devices for use in neurotechnology. We leverage expertise in polymeric biomaterials and flexible electronics for use in next-generation medical devices that can integrate seamlessly with excitable tissue in the human body.
Email: jborenstein@draper.com
Jeffrey T. Borenstein is Group Leader of Synthetic Biology and Bio Instrumentation at Draper, where he leads a research program in the application of microfluidics technologies toward therapeutic devices and tools for drug development. His research focuses on next generation organ assist devices and implantable drug delivery systems for critical care, and on microfluidic organ models for cancer and other diseases.
Email: jc65@ualberta.ca
Tel: (780) 492-9820
Dr. Chen’s interdisciplinary research areas include: (a) MEMS/NMES-based Microfluidic Biosensors: Designing portable impedance-based and colorimetric point-of-care biosensors for detecting genomic/proteomic/metabolic biomarkers in bodily fluids (urine, blood, etc.). (b) Biomedical and Healthcare Devices: Developing a low-intensity pulsed-ultrasound technology platform to stimulate cell growth (with applications in cell therapy, tissue engineering, mental health, and antibody production), as well as microorganism growth (with applications in enhancing sludge activities for wastewater treatment, increasing renewable biofuel/algal oil, antibiotics, omega-3, and wine/beverage production). (c) VLSI and Low-Power Circuits: Designing low-power fault-tolerant nanoscale devices and circuits based on probabilistic Markov Random Field theory.
Tel: (858) 822-7856
Dr. Chen is a pioneer in 3D prinUng and bioprinUng. He has published over 150 journal publicaUons. His research interests include: 3D Printing and Bioprinting, Stem Cells and Tissue Engineering, Biomaterials and Nanomaterials, and Organ/Tissueon-a-Chip.
Dr. Shaochen Chen is a Professor and Chair in the NanoEngineering Department and Professor in the Bioengineering Department at the University of California, San Diego (UCSD). He is the founding co-director of the Biomaterials and Tissue Engineering Center at UCSD. Before joining UCSD, Dr. Chen had been a Professor and a Henderson Centennial Endowed Faculty Fellow in Engineering in the Mechanical Engineering Department at the University of Texas at Austin from 2001 to 2010. Between 2008 and 2010, he served as the Program Director for the Nanomanufacturing Program of the US National Science Foundation (NSF).
Dr. Chen’s primary research interests include: 3D printing and bioprinting, biomaterials and nanomaterials, stem cell and regenerative medicine, and tissue engineering. He has published over 170 papers in top journals.
Among his numerous awards, Dr. Chen received the NSF CAREER award, ONR Young Investigator award, and NIH Edward Nagy New Investigator Award. For his seminal work in 3D printing, bioprinting, and nanomanufacturing, he received the Milton C. Shaw Manufacturing Research Medal from the American Society of Mechanical Engineers (ASME) in 2017. Dr. Chen is an elected member of the US National Academy of Inventors and the European Academy of Sciences and Arts, a Fellow of AAAS, AIMBE, ASME, SPIE, and ISNM. In 2022, Dr. Chen was awarded as a BRITE fellow of NSF to advance the 3D bio-nano-manufacturing techniques. Dr. Chen is a founder of Allegro 3D, Inc. commercializing 3D bioprinting technologies.
Email: G.Cummins@bham.ac.uk
My research primarily focuses on the application of silicon-based micro/nanofabrication and printing technologies to create implantable, ingestible or wearable biomedical microdevices. My current research interests lie in the utilisation of micro/nanofabrication for the creation of ingestible therapeutic and diagnostic microsystems to detect and treat gastrointestinal disease, as well as minimally invasive systems for in-vivo, long-term monitoring. His work in this area has led to two international awards and several invited talks across Europe.
Email: dicarlo@seas.ucla.edu
Phone: (310) 983-3235
Fax: (310) 794-5956
Microfluidics and quantum assays. The Di Carlo Lab leverages microfluidics, microfabrication, and nanotechnologies to develop interfaces with cells and molecules for applications in disease diagnosis, therapeutic discovery, tissue regeneration, and directed evolution. These tools not only excel at the manipulation and analysis of single cells and molecules, but also are cost-effective and easily accessible -- thus democratizing advanced biotechnology capabilities to solve medical problems. Dr. Di Carlo’s innovations have led to further development in a number of startups, often led by students who initially were involved in projects in his lab. These startups are developing diagnostics, therapeutics, and life science research tools, and many are being commercially used.
Email: mdokmeci@mednet.ucla.edu
Dr. Dokmeci has a strong background in designing and fabricating micro- and nano sensors, biomaterials, tissue engineering, implantable devices and encapsulation technologies and biomedical microsystems. He is interested in flexible electronics for monitoring and modulation of wound healing, electrical/electrochemical biosensors and microfluidic systems for organs-on-a-chip applications and 3D bioprinting.
Dr. Dokmeci is Associate Professor at the Terasaki Institute for Biomedical Innovation. Previously, he was an Associate Adjunct Professor in the Radiology Department at the University of California-Los Angeles from November 2017 to June 2020. Prior to that he was an Instructor at Brigham and Women’s Hospital, Harvard Medical School, a position he has held for 7 years. Before then, he was on the faculty of the Electrical and Computer Engineering Department at Northeastern University. Before joining academia, he had 4 years of industrial experience at Corning-Intellisense Corporation, Wilmington, MA, developing MEMS-based products for the telecommunications and life science industries. He has served as the program organizer and chair for many conferences, such as organizer and session chair at the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS Technical Committee on Bio-Micro-Electro-Mechanical Systems (TC-BioMEMS) and Session Chair of Society of Experimental Mechanics Annual Conference, Springfield. he has extensively published in refereed journals and conferences in the areas of MEMS, Micro- and Nanotechnology, and Bio-Chemistry. He is also a long term member of the Institute of Electrical and Electronics Engineers (IEEE), Materials Research Society (MRS), American Chemical Society (ACS), and American Association for the Advancement of Science (AAAS). He has a strong background and more than a decade of experience in designing and fabricating micro and nanoscale sensors and systems, biomedical devices, tissue engineering, and implantable biosensors. He has been actively involved in research areas such as flexible electronics for monitoring and modulation of wound healing, electrical/electrochemical biosensors and microfluidic systems for organs-on-a-chip applications and 3D bioprinting. He has authored more than 175 journal papers, 6 patents/disclosures; 112 conference publications/abstracts, has an h-index=77, citations > 22,250.
Office: ITE 347
Phone: (860) 486-2210
Email: abhishek.dutta@uconn.edu
Dr. Dutta is an Assistant Professor at University of Connecticut with sustained international recognition in cybernetics, control and robotics, neural and biomedical engineering. Dr. Dutta has concurrent appointments in Electrical and Computer Engineering, the United Technologies Corporation - Institute for Advanced Systems Engineering, Biomedical Engineering in the School of Engineering and the Connecticut Institute for the Brain and Cognitive Sciences.
Office: Room 517 in N8-5 Building Lab： Room 516, 511 in N8-5 Building
e-mail: fukuda@ynu.ac.jp
Tel: +81-45-339-4008
Contact information
Faculty of Engineering, Yokohama National University 79-5 Tokiwadai, Hodogaya-ku, Yokohama 240-8501 JAPAN
Prof. Junji Fukuda is a professor of the Faculty of Engineering, Yokohama National University, Japan. He is also an Adjunct Project Leader, KISTEC, Japan and an Associate Investigator, University of Wollongong, Australia. He obtained his master and Ph.D in Chemical Engineering from Kyushu University, Japan. His research area has been in the synthesis, processing, and evaluation of biomaterials for tissue engineering and regenerative medicine.
Research areas: BioMEMS, Biosensor, and Microfluidics
His research interest is to develop Microelectromechanical Systems (MEMS) for biomedical applications. Including sensors microfluidics to produce Lab-on-a-Chip, Point-of-Care systems. Currently, He is focusing on three research topics: (1) Impedimetric monitoring of biological substances in microfluidic systems; (2) 3D printed microfluidics for biological detections (3) Membrane modifications and development towards sensing platforms for biomedical applications.
Email: jabbari@engr.sc.edu
Tel: 803-777-8022
Prof. Jabbari’s research thrusts include the fundamental and practical aspects in the development of novel medical implants for growth factor and stem cell delivery in regenerative medicine and cancer therapy. His research exploits biomimetic principles and micro/nano-scale technologies to develop multi-cellular tissue models to understand the effect of microenvironment on tissue organization and maintenance.
Rm. 724B, Ross Research Building
720 Rutland Avenue
Baltimore, MD 21205
(410) 502-9773
Email: dhkim@jhu.edu
Dr. Kim’s research focuses on development of micro/nano-fabricated platforms for drug efficacy/toxicity screening and microphysiological models of inherited cardiomyopathy and peripheral neuropathy. Using micro/nano-fabricated tools in combination with human pluripotent stem cell technologies, his laboratory also seeks to gain a better understanding of disease biology and contribute to biotherapeutic development.
E-mail: hwlee@purdue.edu
Phone: +1 765 49-624444
Group Page
My research interest centers around improving the reliability and functionality of implantable medical devices using micro and nanoscale transducers. Examples of his research topics include implantable magnetic microactuators, neurostimulation electrodes, and various chronically implantable biochemical sensors. He is a recipient of NSF CAREER award and his lab is currently supported by NIH, NSF, Indiana Clinical and Translational Science Institute, Samsung, and Eli Lilly.
Laboratory: Bio-MEMS Lab
Email: kflei@mail.cgu.edu.tw
Tel: +886-3-2118800 ext. 5345 (Office), 5718 (Lab)
Research areas: Bio-microfluidics; MEMS; Bio-sensing; Cancer biology
His research interest is to develop Micro-ElectroMechanical Systems (MEMS) for bio-medical applications. They highlight the spirit of innovation and high quality up-stream research. Currently, they focus on three research topics: (a) Impedimetric monitoring of biological substances, i.e., cell, DNA, and protein, in microfluidic systems; (b) Paper-based microfluidics for cell-based assays; (c) Inhibition of cancer cell proliferation under electrical stimulation.
mraje@uci.edu
Manasi Raje is an industry professional with a breadth of expertise in Microfluidic systems and DNA synthesis technologies. Her research experience in oligonucleotide/DNA synthesis spans over a variety of chemistries of synthesis including 2D platform based synthesis and 3D bead based synthesis techniques. She has developed microarray based products, target capture microfluidic devices, pneumatic microfluidic computers in the past and is currently developing the cutting edge technology of highly parallel DNA synthesis for DNA data storage.
Guildford, Surrey GU2 7XH, UK (+44) 1483 686775
Dielectrophoresis of cells and nanoparticles, divided between instrumentation development (such as cell
characterization and separation tools, now spun out and commercially available) and fundamental study of the electrical properties of cells. These are used to develop new approaches to understanding cell behaviour, and diagnosing and treating disease.
Tel: 514 848 2424 x7579
The Shih lab is focused on an inter-disciplinary approach of combining engineering, biology, and chemistry to solve novel problems in these fields. Specifically, his group is using droplet-based microfluidic platforms for automating processes in mammalian gene-editing, synthetic biology, directed evolution, and biosensor development. By automating these processes his group can quickly develop novel organisms that can be used to produce renewable sources of fuel and new cellular therapies for eradicating diseases.
Email: maryam.tabrizian@mcgill.ca
Maryam Tabrizian’s research aim at developing hybrid and functional biomaterials and biointerfaces for their applications in regenerative medicine, nanomedicine, immunomodulation and diagnostic tools. This implies the development of biomimetic and 3-D hydrogels, nanocoating on both artificial and biological templates, high throughput synthesis of nanoparticles, and microfluidic lab-on-a chip device.
Professor Xiaowu (Shirley) Tang joined the Department of Chemistry & Waterloo Institute for Nanotechnology (WIN) at the University of Waterloo (UW) in 2006. Currently, she is the Associate Dean of Science, Research, and a member of the Board of Directors for WIN. During 2014-2017, she served as the Director of Nanotechnology Engineering (NE) program, Canada’s only undergraduate NE program. Prior to joining UW, she received her Ph.D. from Massachusetts Institute of Technology (MIT) and pursued postdoctoral work at Stanford University. She also had 3 years of industrial experience in Silicon Valley, California, and is a co-founder of LeNano Diagnostics, Inc, a company incorporated in 2016.
Central to Tang group’s research is the development of intelligent materials and devices for critical medical needs, particularly portable and wearable technologies for personalized and distributed healthcare. Her work has led to publications on prestigious journals, such as Nature Nanotechnology, Nature Biotechnology, Journal of American Chemical Society, Advanced Materials, and Nano Letters, as well as patents, industrial partnerships, media reports, and invited lectures. Prof. Tang received the Leader’s Opportunity Award from Canada Foundation for Innovation (CFI) in 2008, the Stars in Global Health Award from Grand Challenges Canada in 2012, Award for Outstanding Mid-Career Achievements in Nanoscience and Nanotechnology, NanoOntario, in 2018, Research Leaders Award, WIN, in 2021.
Room 38-435
Cambridge, MA 02139
Ph: 617.253.2094
Prof. Voldman’s research focuses on leveraging microscale phenomena to impact biology and medicine.
His lab has developed a number of different approaches for manipulaPng and culturing cells in
microfluidic environments and measuring molecules using electronic immunoassays. He focuses focus on
systems that provide exquisite control over fluids and cells in order to exert control or make precise and
accurate measurements.
Email: shxwang@nwpu.edu.cn
Dr. Shaoxi Wang, associate Professor, is Vice Dean of School of Microelectronics, Northwestern Polytechnical University, in Xi’an China. He is also an IEEE member, IEEE BioCAS TC member and senior member of Chinese Society of Micro-Nano technology. His research interests include 3D integrated circuit cooling with microfluidic, microfluidic chip for biotechnological application and bio-microelectronics.
Email: hwwu@fcu.edu.tw
My research is including semiconductor, bioelectronics, and microwave engineering. In the field of bioelectronics, we proposed a high-efficiency circulating tumor cells screening biochip using the nanocrystalline silicon (nc-Si:H) thin film prepared by 40.68-MHz very high-frequency plasma-enhanced
chemical vapor deposition (VHFPECVD) and the very high-frequency atomic layer
deposition (VHFALD). The quality, uniformity, interface, and electrical properties of the
prepared nc-Si:H thin films affect the performance parameters of the biochip, such as
its recovery rate, purity, and survival rate, for screening circulating tumor cells. The
screening performance of the biochip is highly associated with the quality of the
deposited nc-Si:H thin films; therefore, an appropriate deposition technique is crucial for
applications in a clinical trial.
T: 650-723-0772 (Office)
650-725-8698 (Lab)
F: 650-721-5404
Email: ypyang@stanford.edu
Biomaterials, medical devices, stem cells and bioprinting for musculoskeletal tissue engineering
Email: eelyobas@ust.hk
Tel: +852-2358-7068
My research is mainly focused on silicon-based micro/nanofabrication and lab-on-a-chip micro/nanofluidic technologies for life sciences, drug discovery and point-of-care diagnostics. These technologies often use electrokinetic principles such as electrophoresis, dielectrophoresis, and electrohydrodynamics along with micro/nanostructures such as integrated nanocapillaries and non-planar microelectrodes. Current thrust areas of my research include biomedical microdevices for (a) cell manipulation, sorting, and treatment for the isolation and analysis of rare cells such as circulating tumor cells and (b) rapid biomacromolecule separation for on-chip analysis of proteins and nucleic acids.
For more details, pls refer: https://personal.ntu.edu.sg/yjzheng/
Yuanjin Zheng received his B.Eng. from Xian Jiaotong University, P. R. China in 1993, M. Eng. from Xian Jiaotong University, P. R. China in 1996, and Ph.D. from Nanyang Technological University, Singapore in 2001. From July 1996 to April 1998, he worked at the national key lab of optical communication technology, university of electronic science and technology of China. He joined Institute of Microelectronics, A*STAR on 2001 and developed as a group technical manager. Since then, he has leaded in developing various wireless systems and CMOS integrated circuits, such as Bluetooth, WLAN, WCDMA, UWB, RF SAW/MEMS, Radar, and wireless implant sensors and wearable interface circuits etc. Since July 2009, he joined Nanyang Technological University, and now become a director for VIRTUS, IC design center of excellence, working on various radar system development and hybrid circuit and device (GaN, SAW, MEMS) designs, and flexible noninvasive sensor circuits and systems for biomedical and healthcare applications etc. His current research interest is on low power high frequency integrated circuits, photoacousitics and BioMEMS, 3D imaging and display and Artificial Intelligence. He has authored and coauthored over 450 international journal and conference papers, 26 patents filed, and 5 book chapters. He is currently associate editors for three journals and has been organizing several IEEE conferences as TPC Chairs and Session chairs. He was also a lead guest editor for a special issue of TBioCAS2019, and best paper award of CAS Life Science and Biomedical Circuits track in 2018 ISCAS.
Tel.: 416-946-5295
Email: m.radisic@utoronto.ca
Her research is focused on developing heart-on-a-chip based screening technologies using iPSC that can
facilitate a paradigm shiR to a personalized medicine approach with pre-evaluaUon of agents for safety and efficacy ex vivo, using a paUent’s own normal and diseased Ussues. She is also focused on overcome manufacturing challenges fueling adopUon of these devices and understand the mechanisms at play through genomic and proteomic screens.